Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19
Background and Aim: Liver test abnormalities are common in COVID-19 patients. The aim of our study was to determine risk factors for different liver injury patterns and to evaluate the relationship between liver injury patterns and prognosis in patients with COVID-19.Methods: We retrospectively anal...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2020.584342/full |
id |
doaj-ea0d31105a824b92bef649ded66bfe36 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Huikuan Chu Tao Bai Liuying Chen Lilin Hu Li Xiao Lin Yao Rui Zhu Xiaohui Niu Zhonglin Li Lei Zhang Chaoqun Han Shuangning Song Qi He Ying Zhao Qingjing Zhu Hua Chen Bernd Schnabl Ling Yang Xiaohua Hou |
spellingShingle |
Huikuan Chu Tao Bai Liuying Chen Lilin Hu Li Xiao Lin Yao Rui Zhu Xiaohui Niu Zhonglin Li Lei Zhang Chaoqun Han Shuangning Song Qi He Ying Zhao Qingjing Zhu Hua Chen Bernd Schnabl Ling Yang Xiaohua Hou Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19 Frontiers in Medicine liver impairment hepatocellular pattern cholestatic pattern mixed pattern prognosis |
author_facet |
Huikuan Chu Tao Bai Liuying Chen Lilin Hu Li Xiao Lin Yao Rui Zhu Xiaohui Niu Zhonglin Li Lei Zhang Chaoqun Han Shuangning Song Qi He Ying Zhao Qingjing Zhu Hua Chen Bernd Schnabl Ling Yang Xiaohua Hou |
author_sort |
Huikuan Chu |
title |
Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19 |
title_short |
Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19 |
title_full |
Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19 |
title_fullStr |
Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19 |
title_full_unstemmed |
Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19 |
title_sort |
multicenter analysis of liver injury patterns and mortality in covid-19 |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Medicine |
issn |
2296-858X |
publishDate |
2020-10-01 |
description |
Background and Aim: Liver test abnormalities are common in COVID-19 patients. The aim of our study was to determine risk factors for different liver injury patterns and to evaluate the relationship between liver injury patterns and prognosis in patients with COVID-19.Methods: We retrospectively analyzed patients admitted between January 1st to March 10th, with laboratory-confirmed COVID-19 and followed them up to April 20th, 2020. Information of clinical features of patients was collected for analysis.Results: As a result, a total of 838 hospitalized patients with confirmed COVID-19, including 48.8% (409/838) patients with normal liver function and 51.2% (429/838) patients with liver injury were analyzed. Abnormal liver function tests are associated with organ injuries, hypoxia, inflammation, and the use of antiviral drugs. Hepatocellular injury pattern was associated with hypoxia. The mortality of the hepatocellular injury pattern, cholestatic pattern and mixed pattern were 25, 28.2, and 22.3%, respectively, while the death rate was only 6.1% in the patients without liver injury. Multivariate analyses showed that liver injury with cholestatic pattern and mixed pattern were associated with increased mortality risk.Conclusions: Our study confirmed that hepatocellular injury pattern that may be induced by hypoxia was not risk factor for mortality in SARS-COV-2 infection, while liver injury with mixed pattern and cholestatic pattern that might be induced by SARS-CoV-2 directly might be potential risk factors for increased mortality in COVID-19 patients. |
topic |
liver impairment hepatocellular pattern cholestatic pattern mixed pattern prognosis |
url |
https://www.frontiersin.org/articles/10.3389/fmed.2020.584342/full |
work_keys_str_mv |
AT huikuanchu multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT taobai multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT liuyingchen multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT lilinhu multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT lixiao multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT linyao multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT ruizhu multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT xiaohuiniu multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT zhonglinli multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT leizhang multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT chaoqunhan multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT shuangningsong multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT qihe multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT yingzhao multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT qingjingzhu multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT huachen multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT berndschnabl multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT lingyang multicenteranalysisofliverinjurypatternsandmortalityincovid19 AT xiaohuahou multicenteranalysisofliverinjurypatternsandmortalityincovid19 |
_version_ |
1717378802728828928 |
spelling |
doaj-ea0d31105a824b92bef649ded66bfe362021-09-15T15:17:23ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2020-10-01710.3389/fmed.2020.584342584342Multicenter Analysis of Liver Injury Patterns and Mortality in COVID-19Huikuan Chu0Tao Bai1Liuying Chen2Lilin Hu3Li Xiao4Lin Yao5Rui Zhu6Xiaohui Niu7Zhonglin Li8Lei Zhang9Chaoqun Han10Shuangning Song11Qi He12Ying Zhao13Qingjing Zhu14Hua Chen15Bernd Schnabl16Ling Yang17Xiaohua Hou18Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDivision of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDivision of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDivision of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDivision of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDivision of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Integrated Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaCollege of Informatics, Huazhong Agricultural University, Wuhan, ChinaDivision of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDivision of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDivision of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDivision of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDivision of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaLiver and Infectious Diseases Department, Wuhan Jinyintan Hospital, Wuhan, ChinaLiver and Infectious Diseases Department, Wuhan Jinyintan Hospital, Wuhan, ChinaTuberculosis and Respiratory Department, Wuhan Jinyintan Hospital, Wuhan, ChinaDepartment of Medicine, University of California, San Diego, La Jolla, CA, United StatesDivision of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDivision of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaBackground and Aim: Liver test abnormalities are common in COVID-19 patients. The aim of our study was to determine risk factors for different liver injury patterns and to evaluate the relationship between liver injury patterns and prognosis in patients with COVID-19.Methods: We retrospectively analyzed patients admitted between January 1st to March 10th, with laboratory-confirmed COVID-19 and followed them up to April 20th, 2020. Information of clinical features of patients was collected for analysis.Results: As a result, a total of 838 hospitalized patients with confirmed COVID-19, including 48.8% (409/838) patients with normal liver function and 51.2% (429/838) patients with liver injury were analyzed. Abnormal liver function tests are associated with organ injuries, hypoxia, inflammation, and the use of antiviral drugs. Hepatocellular injury pattern was associated with hypoxia. The mortality of the hepatocellular injury pattern, cholestatic pattern and mixed pattern were 25, 28.2, and 22.3%, respectively, while the death rate was only 6.1% in the patients without liver injury. Multivariate analyses showed that liver injury with cholestatic pattern and mixed pattern were associated with increased mortality risk.Conclusions: Our study confirmed that hepatocellular injury pattern that may be induced by hypoxia was not risk factor for mortality in SARS-COV-2 infection, while liver injury with mixed pattern and cholestatic pattern that might be induced by SARS-CoV-2 directly might be potential risk factors for increased mortality in COVID-19 patients.https://www.frontiersin.org/articles/10.3389/fmed.2020.584342/fullliver impairmenthepatocellular patterncholestatic patternmixed patternprognosis |